Combined Radiation and PD-L1 Blockade Improved Tumor Control in Mouse Head and Neck Squamous Cell Carcinoma (HNSCC)

被引：2
|
作者：
Kamdem, D. T. [1 ]
Steel, J. C. [2 ]
Wise-Draper, T. [1 ]
Kassing, W. M. [3 ]
Sadraei, N. Hashemi [1 ]
Mierzwa, M. L. [4 ]
Morris, J. C. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Univ Hosp, Cincinnati, OH USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 94卷 / 04期
关键词：
D O I：
10.1016/j.ijrobp.2015.12.185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：928 / 928
页数：1
相关论文
共 50 条
  • [41] Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance
    Chen, Shu-Wei
    Li, Si-Hao
    Shi, Ding-Bo
    Jiang, Wen-Mei
    Song, Ming
    Yang, An-Kui
    Li, Yu-Dong
    Bei, Jin-Xin
    Chen, Wen-Kuan
    Zhang, Quan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2019, 34 (04): : 398 - 405
  • [42] The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma
    Wusiman, Dilinaer
    Guo, Lei
    Huang, Zehao
    Li, Zhengjiang
    Liu, Shaoyan
    Ying, Jianming
    Li, Wenbin
    An, Changming
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 236
  • [43] Circulating Plasma Exosomal PD-L1 Predicts Prognosis of Head and Neck Squamous Cell Carcinoma After Radiation Therapy
    Tamari, Keisuke
    Minami, Kazumasa
    Tatekawa, Shotaro
    Seo, Yuji
    Fukusumi, Takahito
    Tanaka, Hidenori
    Suzuki, Motoyuki
    Eguchi, Hirotaka
    Takenaka, Yukinori
    Hirata, Takero
    Hayashi, Kazuhiko
    Isohashi, Fumiaki
    Shimizu, Shinichi
    Koizumi, Masahiko
    Inohara, Hidenori
    Ogawa, Kazuhiko
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (02)
  • [44] Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma
    Schulz, Daniela
    Wetzel, Martin
    Eichberger, Jonas
    Piendl, Gerhard
    Brockhoff, Gero
    Wege, Anja K.
    Reichert, Torsten E.
    Ettl, Tobias
    Bauer, Richard J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [45] Spatial Intratumoral Heterogeneity Expression of PD-L1 Antigen in Head and Neck Squamous Cell Carcinoma
    Hirshoren, Nir
    Al-Kharouf, Issa
    Weinberger, Jeffrey M.
    Eliashar, Ron
    Popovtzer, Aron
    Knaanie, Ariela
    Fellig, Yakov
    Neuman, Tzahi
    Meir, Karen
    Maly, Alexander
    Vainer, Gilad W.
    ONCOLOGY, 2021, : 464 - 470
  • [46] PD-L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling
    Zheng, Anyuan
    Li, Fen
    Chen, Fuhai
    Zuo, Jingjing
    Wang, Lei
    Wang, Yongping
    Chen, Shiming
    Xiao, Bokui
    Tao, Zezhang
    ONCOLOGY REPORTS, 2019, 41 (05) : 2833 - 2843
  • [47] A comparative study of PD-L1 diagnostic assays in squamous cell carcinoma of the head and neck (SCCHN)
    Ratcliffe, M. J.
    Sharpe, A.
    Rebelatto, M.
    Scott, M.
    Barker, C.
    Scorer, P.
    Walker, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
    Puladi, Behrus
    Ooms, Mark
    Kintsler, Svetlana
    Houschyar, Khosrow Siamak
    Steib, Florian
    Modabber, Ali
    Hoelzle, Frank
    Knuechel-Clarke, Ruth
    Braunschweig, Till
    CANCERS, 2021, 13 (17)
  • [49] PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
    Evrard, D.
    Hourseau, M.
    Couvelard, A.
    Paradis, V.
    Gauthier, H.
    Raymond, E.
    Halimi, C.
    Barry, B.
    Faivre, S.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [50] Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
    De Meulenaere, Astrid
    Vermassen, Tijl
    Aspeslagh, Sandrine
    Huvenne, Wouter
    Van Dorpe, Jo
    Ferdinande, Liesbeth
    Rottey, Sylvie
    ORAL ONCOLOGY, 2017, 70 : 34 - 42
12345